Immunocytochemical demonstration of separate vasopressin-neurophysin and oxytocin-neurophysin neurons in the human hypothalamus

Summary With the use of immunocytochemistry, it was shown that both the supraoptic and paraventricular hypothalamic nuclei in humans contain at least two different neurophysins. These two human neurophysins are immunologically related to bovine neurophysin I and neurophysin II, respectively. One human neurophysin is associated with vasopressin, the other with oxytocin. Human vasopressin-neurophysin and oxytocin-neurophysin are located separately in two different types of neurons, which correspond respectively to the vasopressinergic and oxytocinergic neurons of both the supraoptic and paraventricular nuclei. The neurophysin of the human vasopressinergic suprachiasmatic neurons appears to be closely related to or identical with neurophysin of the vasopressinergic neurons of the human magnocellular hypothalamic nuclei.This investigation was supported by a grant from the Belgian Nationaal Fonds voor Geneeskundig Wetenschappelijk Onderzoek     

Pressor response to l-cysteine injected into the cisterna magna of conscious rats involves recruitment of hypothalamic vasopressinergic neurons

The sulfur-containing non-essential amino acid l-cysteine injected into the cisterna magna of adult conscious rats produces an increase in blood pressure. The present study examined if the pressor response to l-cysteine is stereospecific and involves recruitment of hypothalamic vasopressinergic neurons and medullary noradrenergic A1 neurons. Intracisternally injected d-cysteine produced no cardiovascular changes, while l-cysteine produced hypertension and tachycardia in freely moving rats, indicating the stereospecific hemodynamic actions of l-cysteine via the brain. The double labeling immunohistochemistry combined with c-Fos detection as a marker of neuronal activation revealed significantly higher numbers of c-Fos-positive vasopressinergic neurons both in the supraoptic and paraventricular nuclei and tyrosine hydroxylase containing medullary A1 neurons, of l-cysteine-injected rats than those injected with d-cysteine as iso-osmotic control. The results indicate that the cardiovascular responses to intracisternal injection of l-cysteine in the conscious rat are stereospecific and include recruitment of hypothalamic vasopressinergic neurons both in the supraoptic and paraventricular nuclei, as well as of medullary A1 neurons. The findings may suggest a potential function of l-cysteine as an extracellular signal such as neuromodulators in central regulation of blood pressure.     

Changes in metabolic activity of neurons in the anterior hypothalamus nuclei during hyperthermia, fever, and hypothermia

Differently directed changes in metabolic activity of anterior hypothalamic nuclei's neurons in rats during hyperthermia, fever, and hypothermia were revealed with histochemical methods. During hyperthermia, the activity of energy metabolism enzymes increased as well as RNA content in the neurons of supraoptic, paraventricular and median preoptic anterior hypothalamic nuclei. This is shown by an increase in the metabolic activity of neurons of these nuclei. Metabolic activity in neurons of median preoptic nuclei decreased and was not changed considerably in neurons of supraoptic and paraventricular nuclei during endotoxin-induced fever. The development of hypothermia was characterised by a decrease in metabolic activity of neurons of supraoptic, paraventricular and medium preoptic nuclei. It is supposed that differently directed metabolic activity changes in neurons of anterior hypothalamic nuclei during hyperthermia are connected with the mechanisms of body temperature regulation (median preoptic nuclei) and neurosecretory processes (supraoptic and paraventricular nuclei).     

Role of Different Types of Adrenoreceptors in Regulation of Functional Activity of Vasopressinergic Neurosecretory Cells of Rat Hypothalamus

The goal of the present study was to find out by which adrenoreceptors noradrenaline affects synthesis and release of vasopressin from perikarya of neurosecretory cells in paraventricular and supraoptic nuclei of rat hypothalamus and what the character of this effect. In experiments in vitro with incubation of surviving hypothalamic slices in the medium containing noradrenaline or one of antagonists of adrenoreceptors (cirazoline—of ₁-, UK14304—of ₂-, cimaterol—of -adrenoreceptors) it was shown that application of different adrenoreceptor agonists resulted in different changes of the functional state of vasopressinergic cells in the supraoptic and paraventricular nuclei. Comparison of the content of vasopressin mRNA (method of hybridization in situ) and of vasopressin-immunoreactive substance (immunohistochemical method) has allowed us to conclude about different ratios of intensities of vasopressin synthesis and release in these cells under effects of noradrenaline and adrenoreceptor agonists studied. The results obtained indicate that noradrenaline has no effect on intensity of synthesis of vasopressin, but can inhibit its release from perikarya. Meanwhile, noradrenaline via ₁-adrenoreceptors is able to inhibit synthesis of vasopressin and, possibly, its release; via ₂-adrenoreceptors it also inhibits release of vasopressin, but does not affect its synthesis, whereas activation of -adrenoreceptors stimulates vasopressin synthesis by neurons of supraoptic and paraventricular nuclei of rat hypothalamus. The diversity of responses of vasopressinergic system to action of noradrenaline, which has been reported by many authors, seems to be due to predominant involvement of particular types of adrenoreceptors.     

State of the NPY-ergic System of the Hypothalamic Arcuate Nucleus in Rats with Experimentally Induced Diabetes Mellitus

We have carried out a quantitative study of the state of a neuropeptide Y (NPY)-ergic system of the hypothalamic arcuate nucleus (AN) in rats in the norm and in streptozotocin (STZ)-induced diabetes mellitus. The NPY-containing objects were identified using an indirect immunofluorescent technique; a system of digital analysis of images and a special software were used. Analysis of the morphometric parameters of the NPY-immunopositive objects within the AN sections allowed us to classify in an automatic mode such objects as neurons of various sizes, fibers, and terminals, as well as to count the number of objects of each class. In addition, the fluorescent intensity of the objects under study (directly proportional to the concentration and amounts of NPY in these objects) was determined. On the basis of these parameters, criteria of the state of synthesis and secretion of NPY and NPY-ergic innervation in the AN subnuclei were proposed. In control animals, the greatest number of NPY-immunopositive neurons and total content of NPY in the neurons and terminals were observed in the ventrolateral and dorsomedial subnuclei of the AN (vl- and dmAN, respectively); this fact points to the high intensities of NPY synthesis and secretion in these structures. The greatest content of NPY in the nerve terminals within the vlAN zone is indicative of the highest intensity of NPY-ergic afferent influences on this subnucleus. It is concluded that the approach we proposed is adequate enough for integral quantitative estimation of the state of peptidergic systems. The development of STZ-induced diabetes mellitus caused changes in the NPY-ergic system in different AN subnuclei; such changes demonstrated certain specificity. In particular, an increase in the number of immunopositive neurons and the total content of NPY in the neurons of vlAN and the ventromedial AN subnucleus (vmAN), which is evidence in favor of intensification of synthesis of the neuropeptide, was not accompanied by an adequate rise in the NPY content in the terminals located in the subnucleus under study. The content of NPY in the eminentia medianus also decreased. The above data allow us to hypothesize that the NPY-ergic system of the AN under conditions of diabetes mellitus is functionally insufficient.     

Immunocytochemistry of magnocellular neurons of supraoptic and paraventricular nuclei of normal and Brattleboro rats with vasopressin anti-idiotype antibody

Summary A vasopressin anti-idiotype antibody was generated by immunization with purified IgG of a primary vasopressin antiserum. The anti-idiotype antibody immunostained neurons in the supraoptic and paraventricular nuclei of the hypothalamus of normal and Brattleboro rats. The distribution of immunostained perikarya in these hypothalamic nuclei together with the staining of fibers in median eminence and neural lobe was similar to that observed in normal rats with anti-vasopressin and suggests strongly that vasopressinergic neurons are being stained. Absorption studies with vasopressin and a vasopressin-binding receptor protein further indicate that a receptor associated with vasopressinergic neurons is recognized by the anti-idiotype antibody.Supported by NIH grants ES03239, NS18626 and NSF grant BNS-8310914. D.T.P. is the receipient of RCDA award NS00869     

The distribution and mechanism of action of ghrelin in the CNS demonstrates a novel hypothalamic circuit regulating energy homeostasis

The gastrointestinal peptide hormone ghrelin stimulates appetite in rodents and humans via hypothalamic actions. We discovered expression of ghrelin in a previously uncharacterized group of neurons adjacent to the third ventricle between the dorsal, ventral, paraventricular, and arcuate hypothalamic nuclei. These neurons send efferents onto key hypothalamic circuits, including those producing neuropeptide Y (NPY), Agouti-related protein (AGRP), proopiomelanocortin (POMC) products, and corticotropin-releasing hormone (CRH). Within the hypothalamus, ghrelin bound mostly on presynaptic terminals of NPY neurons. Using electrophysiological recordings, we found that ghrelin stimulated the activity of arcuate NPY neurons and mimicked the effect of NPY in the paraventricular nucleus of the hypothalamus (PVH). We propose that at these sites, release of ghrelin may stimulate the release of orexigenic peptides and neurotransmitters, thus representing a novel regulatory circuit controlling energy homeostasis.     

CHANGES IN THE HYPOTHALAMO-NEUROHYPOPHYSICAL NEURO-SECRETORY MATERIALS OF RATS DURING DIFFERENT PHASES OF MORPHINE ADMINISTRATION

Abstract—

• 1 Acute morphine treatment of rats increased the concentration of neuro-secretory material in the posterior pituitary. These changes were accompanied by the presence of more neurosecretory materials in the axons of the hypothalamic supraoptic and paraventricular neurons and in the hypothalamic capillaries and sinuses. In the perikarya of the hypothalamic supraoptic and paraventricular neurons, the neurosecretory material is in a dispersed state.
• 2 Following chronic morphine treatment, neurosecretory material was almost absent from the posterior pituitary, whereas in the perikarya of the supraoptic and paraventricular neurons, congestion of neurosecretory material is observed which is accompanied by the absence of the neurosecretory material from the axons arising from the supraoptic and paraventricular nuclei and from the hypothalamic capillaries and sinuses.
• 3 During nalorphine-induced abstinence, there was sudden reappearance of the neurosecretory material in the posterior pituitary along with the appearance of neurosecretory material in the hypothalamic neurosecretory neuronal tracts, blood capillaries and sinuses together with the dispersion of the neurosecretory materials from the hypothalamic neurosecretory neurons.

     

Corticotropin-releasing factor mRNA in the hypothalamus is affected differently by drinking saline and by dehydration

Corticotropin-releasing factor (CRF) stimulates the synthesis and release of adrenocorticotropin in the anterior pituitary and may help maintain fluid and electrolyte balance. 'Salt-loaded' rats had an increase in CRF mRNA in hypothalamic magnocellular neurons of the paraventricular and supraoptic nuclei and a decrease in message in the parvocellular paraventricular neurons. After salt-loaded rats were adrenalectomized, CRF mRNA increased in the parvocellular cells. In contrast to salt loading, water deprivation lead to a decrease in CRF mRNA in magnocellular and parvocellular neurons. These results show that CRF synthesis within separate populations of hypothalamic neurons is regulated differently under various conditions.     

Development of oxytocin- and vasopressin-network in the supraoptic and paraventricular nuclei of fetal sheep

The hypothalamic supraoptic and paraventricular nuclei consist of oxytocin and arginine vasopressin synthesizing neurons that send projections to the neurohypophysis. A growing body of evidence in adult animals and young animals at near term confirmed the structure and function in the vasopressinergic and oxytocinergic network. However, whether those distinctive neural networks are formed before near term is largely unknown. This study determined the special patterns in location and distribution of oxytocin- and vasopressin-neurons in the paraventricular and supraoptic nuclei from preterm to term in the ovine fetuses. The results showed that oxytocin- and vasopressin-neurons were present in both nuclei at the three gestational time periods (preterm, near term, and term). In the paraventricular nuclei, vasopressin-cells concentrated mainly in the core of the middle magnocellular paraventricular nuclei, and oxytocin-cells were scattered surrounding the core. In the supraoptic nuclei, vasopressin-cells mostly located in the ventral part, and oxytocin-cells in the dorsal part. The data demonstrated that the special distributed patterns of vasopressin- and oxytocin-neuron network have formed in those two nuclei at least from preterm. Intracerebroventricular injection of angiotensin II significantly increased fetal plasma oxytocin and vasopressin levels at preterm, which was associated with an increase of oxytocin- and vasopressin-neuron activity marked with c-fos expression. The data provided new evidence for the structural and functional development of the oxytocin- and vasopressin-network before birth.     

Immunohistochemical identification of neurons containing corticotropin-releasing factor in the rat hypothalamus

A specific rabbit anti-CRF serum and the immunoperoxidase technique were used to show that CRF-containing neurons are mainly distributed in the paraventricular and supraoptic nuclei of the rat hypothalamus. In addition, immunoreactive neurons are scattered in other hypothalamic regions. These neurons are 20--30 micrometers in diameter. From the present and previous investigations it may be concluded that the hypothalamic magnocellular nuclei, i.e., paraventricular and supraoptic, and other hypothalamic accessory nuclei, are the producing sites not only for vasopressin and oxytocin, but also for corticotropin-releasing factor.     

P2X receptors are differentially expressed on vasopressin- and oxytocin-containing neurons in the supraoptic and paraventricular nuclei of rat hypothalamus

In the present study, the distribution of P2X receptor protein and colocalization of P2X receptors with vasopressin and oxytocin in the supraoptic and paraventricular nuclei of rat hypothalamus was studied using double-labeling fluorescence immunohistochemistry. The results showed that vasopressin-containing neurons expressed P2X₂, P2X₄, P2X₅ and P2X₆ receptor and oxytocin-containing neurons expressed P2X₂, P2X₄ and P2X₅ receptors in the supraoptic nucleus. In the paraventricular nucleus, vasopressin-containing neurons expressed P2X₄, P2X₅ and P2X₆ receptors, while oxytocin-containing neurons expressed P2X₄ receptors. This study provides the first evidence that P2X receptor subunits are differentially expressed on vasopressin- and oxytocin-containing neurons in the supraoptic and paraventricular nuclei, and hence, provides a substantial neuroanatomical basis for possible functional interactions between the purinergic and vasopressinergic systems, and the purinergic and oxytocinergic systems in the rat hypothalamus. Wei Guo and Jihu Sun contributed equally to this work.     

Participation of neuronal NO-synthase in regulation of hypothalamus vasopressinergic neurons of rat pups at early stages of postnatal ontogeny

To reveal character of interaction of catecholamines (CA) and NO in regulation of development and of the functional state of vasopressinergic (VP-ergic) neurons of supraoptic (SON) and paraventricular (PVN) nuclei, the female rats were injected intraperitoneally with the inhibitor of CA synthesis α-methyl-p-tyrosine, daily, from the 13th to the 20th days of pregnancy. Rat pups born by the females administered with saline at the same period of pregnancy as well as intact pups and adult rats were used as control. Expression of neuronal NO-synthase (nNOS) in neurons of SON and PVN of rat pups at early stages of postnatal development was found to be significantly higher than the definitive level, which allows suggesting participation of NO in development of hypothalamic VP-ergic neurons. The revealed differences of periods of the maximal nNOS expression in the SON and PVN neurons have permitted suggesting development of SON to be completed earlier than that of PVN. The pups exposed to stress at the last third of embryonic development had a long-lasting effect on the state of VP-ergic neurons of the pups after birth. The nNOS expression in neurons does not change, which suggests that NO is not involved in regulation of VP-ergic neurons after exposure to stress at early stages of ontogenesis. A decrease of CA level in the brain at the last third of embryogenesis led to a long preserved decrease of the functional activity of VP-ergic neurons. The nNOS expression in VP-ergic neurons of SON and PVN rose substantially under effect of a compensatory enhancement of tyrosine hydroxylase (TH) expression in neurons of SON and of an increase of the level of CA-ergic innervation of PVN. Thus, we have shown that a decrease of CA level in the embryonic brain leads to an increase of nNOS expression of hypothalamic VP-ergic neurons of rat pups after birth and that the character of NO action on function of VP-ergic neurons does not differ from that of adult animals as soon as at early stages of ontogenesis.     

The development of the corticoliberin- and vasopressinergic elements of the rat hypothalamus during postnatal ontogeny

In 10--81-day and adult Wistar rats, neurosecretory cells were revealed which react with antisera to corticoliberin and vasopressin. Morphometric analysis of these cells in the supraoptic, paraventricular and anterior commissural nuclei shows that in the latter vasopressinergic cells develop somewhat later than in the supraoptic and paraventricular nuclei. Complete differentiation of neurosecretory cells in all the centres investigated is observed in 2-month animals. Studies were also made on the amount of corticoliberin- and vasopressinergic terminals in the external zone of the median eminence. Vasopressin-immunoreactive fibers are more numerous in young rats than in adult ones. Corticoliberin-positive neurosecretory fibers are more abundant in adult animals. Earlier development of vasopressinergic elements corresponds to a hypothesis of a more ancient origin of nonapeptidergic structures as compared to those producing liberins and statins.     

Co-localization of putative vasopressin receptors and vasopressinergic neurons in rat hypothalamus

Summary Vasopressin and oxytocin are synthesized by neurons in the paraventricular and supraoptic nuclei of hypothalamus. Dense concentrations of vasopressin binding sites have also been localized in these nuclei. Using a vasopressin anti-idiotypic antiserum, a dual immunocytochemical labeling procedure has been employed to elucidate the distribution of putative vasopressin receptors in anatomical relation to vasopressin and oxytocin immunoreactive cells in rat brain. Putative vasopressin receptors are observed in relation to magnocellular neurons in hypothalamus that are vasopressin immunoreactive. They do not appear to be associated with parvocellular vasopressinergic cells or oxytocin immunoreactive neurons. The presence of these presumed autoreceptors would support evidence that vasopressin may autoregulate the activity of magnocellular vasopressinergic neurons in hypothalamus.     

Ciliated neurons and different types of synapses in anterior hypothalamic nuclei of reptiles

Summary The magnocellular paraventricular and supraoptic nuclei and the parvocellular preoptic and periventricular nuclei have been studied by light and electron microscopy in Emys orbicularis, Lacerta agilis and Elaphe longissima. The ultrastructure of cerebrospinal fluid (CSF)-contacting neurons was described in the preoptic and periventricular nuclei of Emys and Lacerta species. Single 9×2+0 cilia similar to those of the CSF-contacting dendritic terminals were found on perikarya of non CSF-contacting nerve cells, in all four investigated nuclei. The cilia project from funnel-like invaginations of the perikarya into the intercellular space. In the neurons of the nuclei studied, granular vesicles were found, their size being mainly 1,600 Å in the paraventricular nucleus, about 1,800 Å in the supraoptic nucleus, 1,100 Å in the periventricular nucleus and 800 Å, or up to 1,250 Å in the preoptic nucleus. In general, the neurons possess synapses of the axo-somatic, axo-somatic spine, axo-dendritic and axo-dendritic spine types. In the supraoptic nucleus, multiple interdigitated synapses were observed. Presynaptically, either synaptic vesicles only, or synaptic vesicles and dense core vesicles of different sizes (600 to 800 Å, about 1,100 Å, 1250 Å, and up to 2,000 Å) were found. It is discussed whether the above described 9×2+0 cilia may represent some kind of hypothalamic sensory structure that earlier physiological studies postulated to exist. The ciliated hypothalamic perikarya are considered by the authors to be a more differentiated form of the CSF-contacting neurons. The different types of synapses indicate multilateral connections of the nerve cells of the nuclei studied.Dedicated to Prof. Dr. Berta Scharrer on the occasion of her 70th birthday     

Co-localization of putative vasopressin receptors and vasopressinergic neurons in rat hypothalamus

Vasopressin and oxytocin are synthesized by neurons in the paraventricular and supraoptic nuclei of hypothalamus. Dense concentrations of vasopressin binding sites have also been localized in these nuclei. Using a vasopressin anti-idiotypic antiserum, a dual immunocytochemical labeling procedure has been employed to elucidate the distribution of putative vasopressin receptors in anatomical relation to vasopressin and oxytocin immunoreactive cells in rat brain. Putative vasopressin receptors are observed in relation to magnocellular neurons in hypothalamus that are vasopressin immunoreactive. They do not appear to be associated with parvocellular vasopressinergic cells or oxytocin immunoreactive neurons. The presence of these presumed autoreceptors would support evidence that vasopressin may autoregulate the activity of magnocellular vasopressinergic neurons in hypothalamus.     

Expression of neuropeptide Y and agouti-related peptide in the hypothalamic arcuate nucleus of newborn neurogenin3 null mutant mice

Mice deficient in neurogenin 3 (Ngn3) fail to generate pancreatic endocrine cells and intestinal endocrine cells. Hypothalamic neuropeptides implicated in the control of energy homeostasis might also be affected in Ngn3 homozygous null mutant mice. We investigated the expression of two prominent orexigenic neuropeptides, neuropeptide Y (NPY) and agouti-related protein (AgRP), in the hypothalamic arcuate nucleus of newborn wild-type and Ngn3 null mutant mice. Immunohistochemical analysis demonstrated that, in Ngn3 null mutants, the number of NPY-immunoreactive neurons and nerve fibers was markedly increased in the arcuate nucleus, and the nerve fibers were widely distributed in the hypothalamic area, including the paraventricular and dorsomedial nuclei. Little increase of AgRP immunoreactivity was detected in the arcuate nucleus of mutant mice. In situ hybridization analysis confirmed the increased population of the NPY neurons in the arcuate nucleus of the mutants. The NPY mRNA level, as estimated by laser capture microdissection and real-time quantitative polymerase chain reaction, was 371% higher in Ngn3 null mutants than in wild-type mice. AgRP mRNA levels did not differ significantly between the null mutants and wild-type mice. Thus, up-regulation of the hypothalamic NPY system is probably a feature characteristic of Ngn3 null mice.     

Differentiation of Magnocellular Vasopressinergic Neurons and Its Regulation by Signal Molecules in Ontogenesis

An analysis is presented of the literary data on differentiation of magnocellular vasopressinergic (VPergic) neurons and their regulation by signal molecules in ontogenesis. The VPergic neurons are formed in ontogenesis from cells-precursors of the III ventricle wall; after that, they migrate first into the supraoptic nucleus and then into the paraventricular and accessory nuclei of hypothalamus. At the migration period or at once after migration of the neurons a gene expression and synthesis of preprovasopressin (prepro-VP) occurs. The enzymatic processing of prepro-VP with a formation of functionally active VP begins somewhat later than synthesis of preprohormone. Axons of the VPergic neurons reach the posterior lobe of pituitary before or at once after migration of the neurons into the magnocellular nuclei. Much later, at the perinatal period, the mechanisms of VP release from axons into the general circulation are formed. At the end of prenatal period, the neurons start responding to functional stimulation by an increase of synthesis of the prepro-VP mRNA and peptide itself, as well as by expression of the tyrosine hydroxylase after birth. Differentiation of the VPergic neurons is affected by a short-term or long-term (imprinting) action of catecholamines, neuropeptides, and several hormones of endocrine glands.